Skip to main content
Advanced Search
Search Terms
Content Type

Exact Matches
Tag Searches
Date Options
Updated after
Updated before
Created after
Created before

Search Results

6557 total results found

153 - ECG changes QT prolongation

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

ECG changes – QT prolongation

154 - Introduction

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Introduction

155 - QT prolongation

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

QT prolongation Schizophrenia and related psychoses CHAPTER 1 ECG changes – QT prolongation Introduction Many psychotropic drugs are associated with ECG changes and some are causally linked to serious ventricular arrhythmia and sudden cardiac death. Specifical...

156 - Other ECG changes

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Other ECG changes

157 - Quantifying risk

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Quantifying risk 162 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 ■ ■There is some controversy over the exact association between QTc and risk of arrhythmia. Very limited evidence suggests that risk is exponentially related to the extent of pro...

158 - Other risk factors

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Other risk factors 164 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Aripiprazole remains in the low-effect group having previously been firmly placed in ‘no effect’. Data are rather contradictory, with most studies showing a decrease in QTc ass...

159 - ECG monitoring

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

ECG monitoring

16 - Adverse effects

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Adverse effects 18 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 A small number of RCTs have examined the efficacy of high versus standard dosage in patients with treatment-­resistant schizophrenia (TRS).1 Some have demonstrated benefit23 but th...

160 - Metabolic inhibition

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Metabolic inhibition Schizophrenia and related psychoses CHAPTER 1 Table 1.37  Non-­psychotropics associated with QT prolongation (see Crediblemeds.org for latest information; this is not a complete list). Antibiotics Erythromycin Clarithromycin Ampicillin Co-...

161 - Other cardiovascular risk factors

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Other cardiovascular risk factors

162 - Summary

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Summary

163 - References

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

References 166 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Other cardiovascular risk factors The risk of drug-­induced arrhythmia and sudden cardiac death with psychotropics is an important consideration. With respect to cardiovascular disease...

164 - Effects of antipsychotic medications on plasm

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Effects of antipsychotic medications on plasma lipids

165 - Effect of antipsychotic medications on lipids

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Effect of antipsychotic medications on lipids

166 - Olanzapine

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Olanzapine Schizophrenia and related psychoses CHAPTER 1 Effects of antipsychotic medications on plasma lipids Morbidity and mortality from cardiovascular disease are higher in people with schizophrenia than in the general population.1–3 Dyslipidaemia is an es...

167 - Clozapine

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Clozapine

168 - Screening and monitoring

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Screening and monitoring

169 - Clinical management of dyslipidaemia

Maudsley's guidelines 06 - Chapter 1 Schizophrenia and relate...

Clinical management of dyslipidaemia 170 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 treated with olanzapine or risperidone gained a similar amount of weight, but with olanzapine, serum triglyceride levels increased by four times as much (105m...